Key Takeaways
- Clinical Bottom Line
- The Triopoly of Flexible Endoscopy
Clinical Bottom Line
| Manufacturer | Flagship Series (2026) | Proprietary Optical Technology |
|---|---|---|
| Olympus | EVIS X1 | Narrow Band Imaging (NBI); TXI (Texture and Color Enhancement). |
| Fujifilm | ELUXEO 7000 | Blue Laser Imaging (BLI) and Linked Color Imaging (LCI). |
| Pentax | INSPIRA | i-scan (Digital contrast enhancement) and OE (Optical Enhancement). |
The Triopoly of Flexible Endoscopy
The global flexible endoscope market is overwhelmingly dominated by three major Japanese optical engineering conglomerates. While each system performs the fundamental mechanical task of entering the GI tract, their proprietary methods for enhancing mucosal contrast functionally dictate the specific training and diagnostic algorithms utilized by endoscopists.
Optical Competition
Olympus has historically maintained the dominant market share, primarily driven by the early adoption of Narrow Band Imaging (NBI), which utilizes physical optical filters to isolate blue/green wavelengths, sharply contrasting the brown microvascular patterns characteristic of dysplasia. Fujifilm competes heavily in the premium tier by abandoning Xenon bulbs entirely in favor of multi-LED and true Laser illumination, driving their highly saturated BLI and LCI modalities which significantly increase the detection rate of flat serrated adenomas in the right colon.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
